{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:12:53Z","timestamp":1792876373326,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Histologic growth patterns (HGPs) of both peritoneal metastasis (PM) and liver metastasis (LM) have emerged as prognostic factors for patients undergoing curative surgery for metastatic colorectal cancer (CRC). The main objectives of the study were, first, to evaluate the correlation between PMHGP and LMHGP of CRC patients who underwent curative-intent cytoreductive surgery (CRS) and LM resection and, second, to assess the prognostic impact of HGP type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective bicentric study included patients treated with both CRS and LM resection for metastatic CRC. Histologic growth patterns were classified as pushing (P-HGP) and infiltrating (I-HGP) for PM, and as desmoplastic HGP (D-HGP) and non-desmoplastic (ND-HGP) for LM. Correlation between PMHGP and LMHGP was assessed using the chi-square test. Overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan-Meier and Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 44 patients. Of the 44 patients, 9 (20.5%) had P-HGP + D-HGP, 23 (52.3%) had I-HGP + ND-HGP, 5 (11.4%) had P-HGP + ND-HGP, and 7 (15.9%) had I-HGP + D-HGP. Significant correlation was observed between PMHGP and LMHGP (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0085; \u03a6 = 0.3965). The patients with I-HGP + ND-HGP had shorter OS and DFS than those with other combinations: 34 versus 64 months (HR, 2.067;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0672) for OS, and 14 versus 25 months (hazard ratio [HR], 1.775;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.1071) for DFS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlighted a significant correlation between PMHGP and LMHGP in metastatic CRC. However, survival trends were nonsignificant.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20005-8","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:58:04Z","timestamp":1782737884000},"page":"10415-10424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlations Between the Histologic Growth Patterns of Peritoneal and Liver Metastases From Colorectal Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"No\u00e9mie","family":"Zenaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charif","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Demetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sclafani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Veron","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Donckier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"20005_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"key":"20005_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1634\/theoncologist.12-7-825","volume":"12","author":"N Kemeny","year":"2007","unstructured":"Kemeny N. Presurgical chemotherapy in patients being considered for liver resection. Oncologist. 2007;12:825\u201339. https:\/\/doi.org\/10.1634\/theoncologist.12-7-825.","journal-title":"Oncologist."},{"key":"20005_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","volume":"244","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254\u20139. https:\/\/doi.org\/10.1097\/01.sla.0000217629.94941.cf.","journal-title":"Ann Surg."},{"key":"20005_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejso.2015.11.011","volume":"42","author":"M Barat","year":"2016","unstructured":"Barat M, Soyer P, Eveno C, et al. The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: results of a case-control study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2016;42:266\u201372. https:\/\/doi.org\/10.1016\/j.ejso.2015.11.011.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol."},{"key":"20005_CR5","doi-asserted-by":"publisher","unstructured":"Capussotti L, ed. Surgical Treatment of Colorectal Liver Metastases. Springer, Milan, 2011. https:\/\/doi.org\/10.1007\/978-88-470-1809-9.","DOI":"10.1007\/978-88-470-1809-9"},{"key":"20005_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"key":"20005_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","volume":"100","author":"D Baratti","year":"2016","unstructured":"Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010\u20132015: a systematic review. Crit Rev Oncol Hematol. 2016;100:209\u201322. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.017.","journal-title":"Crit Rev Oncol Hematol."},{"key":"20005_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/CLEP.S34285","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283\u2013301. https:\/\/doi.org\/10.2147\/CLEP.S34285.","journal-title":"Clin Epidemiol."},{"key":"20005_CR9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","volume":"94","author":"PC Simmonds","year":"2006","unstructured":"Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982\u201399. https:\/\/doi.org\/10.1038\/sj.bjc.6603033.","journal-title":"Br J Cancer."},{"key":"20005_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2020.07.038","volume":"47","author":"R Lo Dico","year":"2021","unstructured":"Lo Dico R, Faron M, Yonemura Y, et al. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021;47:89\u2013100. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.038.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol."},{"key":"20005_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2023;34:10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"key":"20005_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28:63\u20138. https:\/\/doi.org\/10.1200\/JCO.2009.23.9285.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"20005_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg. 1999;230:309.","journal-title":"Ann Surg."},{"key":"20005_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10585-023-10221-x","volume":"40","author":"A Bohlok","year":"2023","unstructured":"Bohlok A, Tonneau C, Vankerckhove S, et al. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer. Clin Exp Metastasis. 2023;40:431\u201340. https:\/\/doi.org\/10.1007\/s10585-023-10221-x.","journal-title":"Clin Exp Metastasis."},{"key":"20005_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.annonc.2021.03.206","volume":"32","author":"A Grothey","year":"2021","unstructured":"Grothey A, Fakih M, Tabernero J. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines. Ann Oncol Off J Eur Soc Med Oncol. 2021;32:959\u201367. https:\/\/doi.org\/10.1016\/j.annonc.2021.03.206.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"key":"20005_CR16","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1245\/s10434-022-12736-1","volume":"30","author":"A El Asmar","year":"2023","unstructured":"El Asmar A, Delcourt M, Kamden L, et al. Prognostic value of preoperative serological biomarkers in patients undergoing curative-intent cytoreductive surgery for colorectal cancer peritoneal metastases. Ann Surg Oncol. 2023;30:1863\u20139. https:\/\/doi.org\/10.1245\/s10434-022-12736-1.","journal-title":"Ann Surg Oncol."},{"key":"20005_CR17","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1245\/s10434-023-14840-2","volume":"31","author":"R Grange","year":"2024","unstructured":"Grange R, Rousset P, Williet N, et al. Metastatic colorectal cancer treated with combined liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): predictive factors for early recurrence. Ann Surg Oncol. 2024;31:2378\u201390. https:\/\/doi.org\/10.1245\/s10434-023-14840-2.","journal-title":"Ann Surg Oncol."},{"key":"20005_CR18","doi-asserted-by":"publisher","unstructured":"Nielsen K, Rolff HC, Eefsen RL, Vainer B. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol Off J U S Can Acad Pathol Inc. 2014;27:1641\u20138. https:\/\/doi.org\/10.1038\/modpathol.2014.4.","DOI":"10.1038\/modpathol.2014.4"},{"key":"20005_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10585-012-9469-1","volume":"29","author":"GG Van den Eynden","year":"2012","unstructured":"Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis. 2012;29:541\u20139. https:\/\/doi.org\/10.1007\/s10585-012-9469-1.","journal-title":"Clin Exp Metastasis."},{"key":"20005_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s00268-002-6267-y","volume":"26","author":"J Yamaguchi","year":"2002","unstructured":"Yamaguchi J, Komuta K, Matsuzaki S, Okudaira S, Fujioka H, Kanematsu T. Mode of infiltrative growth of colorectal liver metastases is a useful predictor of recurrence after hepatic resection. World J Surg. 2002;26:1122\u20135. https:\/\/doi.org\/10.1007\/s00268-002-6267-y.","journal-title":"World J Surg."},{"key":"20005_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/jso.26466","volume":"123","author":"A Bohlok","year":"2021","unstructured":"Bohlok A, Duran Derijckere I, Azema H, et al. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases. J Surg Oncol. 2021;123:1773\u201383. https:\/\/doi.org\/10.1002\/jso.26466.","journal-title":"J Surg Oncol."},{"key":"20005_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.966","volume":"195","author":"PB Vermeulen","year":"2001","unstructured":"Vermeulen PB, Colpaert C, Salgado R, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol. 2001;195:336\u201342. https:\/\/doi.org\/10.1002\/path.966.","journal-title":"J Pathol."},{"key":"20005_CR23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/bjc.2017.334","volume":"117","author":"PJ van Dam","year":"2017","unstructured":"van Dam PJ, van der Stok EP, Teuwen LA, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer. 2017;117:1427\u201341. https:\/\/doi.org\/10.1038\/bjc.2017.334.","journal-title":"Br J Cancer."},{"key":"20005_CR24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41416-022-01859-7","volume":"127","author":"E Latacz","year":"2022","unstructured":"Latacz E, H\u00f6ppener D, Bohlok A, et al. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br J Cancer. 2022;127:988\u20131013. https:\/\/doi.org\/10.1038\/s41416-022-01859-7.","journal-title":"Br J Cancer."},{"key":"20005_CR25","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1245\/s10434-023-13118-x","volume":"30","author":"A El Asmar","year":"2023","unstructured":"El Asmar A, Demetter P, Fares F, et al. The prognostic value of distinct histological growth patterns of colorectal peritoneal metastases: a pilot study. Ann Surg Oncol. 2023;30:3320\u20138. https:\/\/doi.org\/10.1245\/s10434-023-13118-x.","journal-title":"Ann Surg Oncol."},{"key":"20005_CR26","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1245\/s10434-024-15125-y","volume":"31","author":"L Kamdem","year":"2024","unstructured":"Kamdem L, Asmar AE, Demetter P, et al. Retrospective evaluation of the prognostic value of histological growth pattern in patients with colorectal peritoneal metastases undergoing curative-intent cytoreductive surgery. Ann Surg Oncol. 2024;31:3778\u201384. https:\/\/doi.org\/10.1245\/s10434-024-15125-y.","journal-title":"Ann Surg Oncol."},{"key":"20005_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13046-023-02729-7","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhong X, He X, et al. Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches. J Exp Clin Cancer Res CR. 2023;42:177. https:\/\/doi.org\/10.1186\/s13046-023-02729-7.","journal-title":"J Exp Clin Cancer Res CR."},{"key":"20005_CR28","doi-asserted-by":"publisher","first-page":"1260880","DOI":"10.3389\/fonc.2023.1260880","volume":"13","author":"A Bohlok","year":"2023","unstructured":"Bohlok A, Richard F, Lucidi V, et al. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers. Front Oncol. 2023;13:1260880. https:\/\/doi.org\/10.3389\/fonc.2023.1260880.","journal-title":"Front Oncol."},{"key":"20005_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2020.07.002","volume":"71","author":"E Latacz","year":"2021","unstructured":"Latacz E, van Dam PJ, Vanhove C, et al. Can medical imaging identify the histopathological growth patterns of liver metastases? Semin Cancer Biol. 2021;71:33\u201341. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.002.","journal-title":"Semin Cancer Biol."},{"key":"20005_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcancer.2020.07.007","volume":"71","author":"RC Oliveira","year":"2021","unstructured":"Oliveira RC, Alexandrino H, Cipriano MA, Alves FC, Tralh\u00e3o JG. Predicting liver metastases growth patterns: current status and future possibilities. Semin Cancer Biol. 2021;71:42\u201351. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.007.","journal-title":"Semin Cancer Biol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20005-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:25:32Z","timestamp":1792207532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20005"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20005-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}